Diclox Patch 30ct System
Product Images NDC 87234-0405

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Diclox Patch 30ct (NDC 87234-0405). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Injecta Medcial Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

526d2a57 7f63 2ca2 E063 6394a90ae710

This is a description of a diclofenac epolamine topical system with a concentration of 1.3%. The product comes in a specific packaging with the NDG number 87234-0405-03. The text also mentions some instructions or information about how to use the product, including the phrase "Cransn e sty e st e s 12". It appears to be a medication or treatment for topical application.*

FDA Label Image

Chemical Structure (Chemical Structure Diclo)

FDA Label Image

Clinical Studies (Clinical Studies Diclo)

FDA Label Image

Package (Diclofenac Patch 87234040503 30ct)

FDA Label Image

Adverse Reactions (Table 1 Diclof)

This text provides a breakdown of common adverse events experienced by patients treated with Diclofenac Epolamine Topical System 1.3% compared to a placebo. Adverse events are categorized by body system and preferred term, with percentages of patients affected listed. The table also notes that adverse events observed in the placebo group could be due to non-active ingredients in the placebo medication. Some specific adverse events mentioned include pruritus, dermatitis, burning, gastrointestinal disorders, and nervous system disorders. The text emphasizes the potential impact of active and inactive ingredients on adverse event occurrence.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.